Employer strategies to manage costs for rare diseases
With growing concerns about the rising costs, employers need to have strategies in place to address the burden of rare dieseases.
By Denise Giambalvo and Dawn Weddle|November 03, 2021 at 09:29 AM
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
Specialty medications for costly diseases such as cystic fibrosis, hemophilia, rheumatoid arthritis, and multiple sclerosis account for close to 50% of the total drug spend in America. While medications for these rare diseases can have a significant impact on health outcomes and improved quality of life, they often come at a steep price for employers.
The high price tag these drugs often carry can be a significant burden not only for the employer but also the patient. With growing concerns about the rising costs, employers need to have strategies in place to manage.
Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.
Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive:
Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
'Tis the season for changes to primary medical plans. Download this infographic and learn 4 actionable solutions to help save your clients from the gloom of a new primary plan reality before it's too late.